# Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive Population

> **NCT07652567** · NA · COMPLETED · sponsor: **Qilu Hospital of Shandong University** · enrollment: 690 (actual)

## Conditions studied

- High-normal Blood Pressure

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Indapamide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07652567
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 690 (ACTUAL)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652567, "Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive Population". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*